These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 3091115
1. Biological and immunological characterization of ATG and ALG. Raefsky EL, Gascon P, Gratwohl A, Speck B, Young NS. Blood; 1986 Sep; 68(3):712-9. PubMed ID: 3091115 [Abstract] [Full Text] [Related]
8. [A long-term follow up study on 345 severe aplastic anemia patients treated with antithymocyte globulin/lymphoglobulin]. Shao YQ, Li XX, Ge ML, Shi J, Zhang J, Huang JB, Huang ZD, Nie N, Zheng YZ. Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):30-5. PubMed ID: 23597461 [Abstract] [Full Text] [Related]
9. Lymphocyte phenotype and lymphokines following anti-thymocyte globulin therapy in patients with aplastic anaemia. Platanias L, Gascon P, Bielory L, Griffith P, Nienhuis A, Young N. Br J Haematol; 1987 Aug; 66(4):437-43. PubMed ID: 3117088 [Abstract] [Full Text] [Related]
10. In vitro immunoglobulin production, proliferation, and cell markers before and after antithymocyte globulin therapy in patients with aplastic anemia. Lum LG, Seigneuret MC, Doney KC, Storb R. Am J Hematol; 1987 Sep; 26(1):1-15. PubMed ID: 2820224 [Abstract] [Full Text] [Related]
12. [Adverse effects of anti-thymocyte globulin/anti-lymphocyte globulin therapy]. Kobayashi R, Kaneda M, Watanabe N, Iguchi A, Cho Y, Yoshida M, Arioka H, Naito H, Shikano T, Ishikawa Y. Rinsho Ketsueki; 1999 Jul; 40(7):531-5. PubMed ID: 10483134 [Abstract] [Full Text] [Related]
13. Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin. Gascon P, Zoumbos NC, Scala G, Djeu JY, Moore JG, Young NS. Blood; 1985 Feb; 65(2):407-13. PubMed ID: 2981588 [Abstract] [Full Text] [Related]
15. Comparison of rabbit antithymocyte globulin and Jurkat cell-reactive anti-T lymphocyte globulin as a first-line treatment for children with aplastic anemia. Xie X, Shi W, Zhou X, Shao Y, Qiao X. Exp Hematol; 2014 Jun; 42(6):431-8. PubMed ID: 24582815 [Abstract] [Full Text] [Related]
17. Specific antibody-blocking activities in antilymphocyte globulin as correlates of efficacy for the treatment of aplastic anemia. Smith AG, O'Reilly RJ, Hansen JA, Martin PJ. Blood; 1985 Sep; 66(3):721-3. PubMed ID: 2411312 [Abstract] [Full Text] [Related]
18. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study. Shin SH, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Kim HJ, Cho SG, Kim DW, Min WS, Park CW, Lee JW. Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980 [Abstract] [Full Text] [Related]
19. Detection of a novel specificity (CTLA-4) in ATG/TMG globulins and sera from ATG-treated leukemic patients. Pistillo MP, Tazzari PL, Bonifazi F, Bandini G, Kato T, Matsui T, Nishioka K, Conte R, Ferrara GB. Transplantation; 2002 Apr 27; 73(8):1295-302. PubMed ID: 11981425 [Abstract] [Full Text] [Related]
20. Different outcomes between cyclophosphamide plus horse or rabbit antithymocyte globulin for HLA-identical sibling bone marrow transplant in severe aplastic anemia. Atta EH, de Sousa AM, Schirmer MR, Bouzas LF, Nucci M, Abdelhay E. Biol Blood Marrow Transplant; 2012 Dec 27; 18(12):1876-82. PubMed ID: 22796534 [Abstract] [Full Text] [Related] Page: [Next] [New Search]